Maunjaro launches in Korea! All the information you need, including release date, price, benefits, and insurance.

Finally, you can meet Maunjaro in Korea.

It is attracting attention all over the world This innovative obesity treatment As it enters the domestic market, full-scale competition with Wegobi is expected to begin.

 

✅ When is the release date for Mounter?

 

Korea Lily plans to supply Maunjaro domestically, aiming for wholesale shipment in mid-August 2025, or August 20 to be exact.

The initial quantities coming in this time are 2.5mg and 5mg It is a low-capacity product,
Higher dose products such as 7.5mg, 10mg, 12.5mg, and 15mg are planned to be introduced in the future.

 

Initial treatment can be started sufficiently with a low dose, and the dose is adjusted by increasing it by 2.5 mg every 4 weeks.

 

 

💰 How much does a mount cost?

 

The current retail price of Wegobi distributed domestically is approximately 370,000 won.

Compared to this, the Maunjaro will be released at a price 10-20% cheaper.

 

The actual patient burden when prescribing at a hospital is Around 400,000 to 600,000 won is expected,
Although the initial cost burden may be somewhat high, the factory price itself is expected to be set lower than the Wigobi, so it is expected to be competitively priced.

 

 

🧬 What is the effect of Maunjaro?

 

Maunjaro is a dual agonist that acts simultaneously on GIP and GLP-1 receptors.

This makes it excellent for blood sugar control and weight loss.
In a 72-week clinical trial, an average weight loss rate of 20.2% was recorded.
It showed a better effect than Wegobi (13.7%).

 

 

👩‍⚕️ Who can get a prescription for Maunja?

 

• - Obese patients with a BMI of 30 or higher
  - Overweight patients with a BMI of 27-30 and comorbidities such as hypertension, hyperlipidemia, diabetes, and sleep apnea
  - Adults with type 2 diabetes
•  

These people can receive a prescription after consulting a specialist.

 

 

📌 Does the insurance cover the Maunja? When will the benefits be paid?

 

Currently, it is classified as a non-covered treatment and the full cost must be borne by the patient.

 

But there is good news.

Korean Lily is currently Indications for diabetes We are currently in the process of applying for health insurance benefits for Maunjaro.
After consultation with the Health Insurance Review & Assessment Service (HIRA),
The situation has entered the subcommittee stage before being submitted to the Pharmaceutical Benefits Evaluation Committee.

 

Lilly's side said, "Since we applied for reimbursement as a new drug, there is a schedule, but the schedule may be flexible due to supplementary data, etc."

 

 

Meanwhile, the academic world is also emphasizing the need for salary system.

The Korean Diabetes Association specifies the ingredient names in its treatment guidelines.
We have established the basis for the salary entry of Maunjaro and Wigobi,
“It is also possible to introduce safety measures, such as stopping salaries in case of lack of performance,” he said.

 

Along with the change in social perception of obesity treatment,
It is expected that discussions on salary reform will become more intense in the future.

 

 

📊 Maunjaro vs. Wigobi Comparison

item	Maunjaro	Wegobi
ingredient	Terzepatide (GIP+GLP-1)	Semaglutide (GLP-1)
Weight loss effect	Average 20.2%	Average 13.7%
Dosage cycle	once a week	once a week
price	10-20% cheaper than Wegobi	Approximately 370,000 won (based on factory price)
insurance	Currently not covered (coverage in progress)	Non-covered

 

 

 

If you organize it in Maunja, it's like this

 

• - Domestic release confirmed for Maunjaro in mid-August
  - Starting with low capacity, with higher capacity to be introduced sequentially
  - Cheaper and more effective than Wegobi
  - Currently not covered by insurance, but plans are underway to make it covered.
  - Future insurance coverage is expected to influence the market landscape.
•  

 

 

I'm looking forward to this medicine, which is cheaper than Wegobi and more effective!!

What do you guys think?? 🤔

 

[Health Column] 7 Things to Know Before Prescribing Wegobi, an Obesity Treatment

- Are the side effects of Wegobi serious? Are the effects not that great?